TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.
Knight JF, Shepherd CJ, Rizzo S, Brewer D, Jhavar S, Dodson AR, Cooper CS, Eeles R, Falconer A, Kovacs G, Garrett MD, Norman AR, Shipley J, Hudson DL.
Knight JF, et al.
Br J Cancer. 2008 Dec 2;99(11):1849-58. doi: 10.1038/sj.bjc.6604774. Epub 2008 Nov 11.
Br J Cancer. 2008.
PMID: 19002168
Free PMC article.